靶向 NY-ESO-1 的保守高亲和力 TCR 工程化 CD4 TCR T 细胞用于癌症晚期细胞治疗
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.
68.9分
★★★☆☆
站内排序·非疗效
ALL SOURCES
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。